Behavioral Economics-Based Online Lifestyle Balance Program

August 20, 2018 updated by: Prof Ho Teck Hua, National University of Singapore
The objective of this project is to design a Behavioral Economics Based Online Lifestyle Balance Program that employs behavioral economics to engage and motivate adherence to an Internet-based program. The investigators compare the effects of two financial incentives on inducing weight loss: a direct financial incentive for weight loss and a financial incentive for health literacy.

Study Overview

Detailed Description

This project investigates whether participants in an online weight loss program can be induced to achieve weight loss using financial incentives. The study is a 3-arm randomized controlled trial (RCT) stratified by gender. The goal is to examine how overweight individuals respond to two different types of financial incentives. The first type of incentive, incentive for weight loss (IW), is a cash award of approximately $150 given for achieving 5% weight loss over 12 weeks. The second type of incentive, incentive for education (IE), is a $150 award for passing quizzes that test the participants' health literacy about weight loss and the techniques required for maintaining a healthy lifestyle. The investigators compare the effectiveness of IW to IE in promoting weight loss in overweight individuals and investigate whether the two incentives work equally well for men and women.

Study Type

Interventional

Enrollment (Actual)

710

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Singapore, Singapore, 119077
        • National University of Singapore

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 60 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • BMI between 23 and 33
  • Age between 40 and 60 years old

Exclusion Criteria:

  • History of diabetes
  • History of significant cardiovascular disease
  • Family history of atherosclerosis
  • High blood pressure
  • Significant lung disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: FACTORIAL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
NO_INTERVENTION: Control

Participants are enrolled in a 12-week, self-administered online weight loss program. The program is delivered through 12 weekly sessions; each includes educational videos and a health literacy quiz. Each quiz contains 10 questions, and a quiz is considered "passed" when at least 7 questions are answered correctly. All participants are encouraged to follow the program, take the quizzes, and lose 5% of their baseline body weight by the end of the program.

No financial incentives are given for losing weight or passing quizzes.

EXPERIMENTAL: Incentive for Education

Same 12-week, self-administered online weight loss program as in the Control arm.

Each participant is also given a $150 "Incentive for Education" for passing at least nine quizzes by the end of the program.

A $150 "Incentive for Education" is given to the participants for passing at least nine quizzes by the end of the program
EXPERIMENTAL: Incentive for Weight Loss

Same 12-week, self-administered online weight loss program as in the Control arm.

Each participant is also given a $150 "Incentive for Weight Loss" for losing 5% of their baseline body weight.

A $150 "Incentive for Weight Loss" is given to the participants for losing at least 5% of baseline weight by the end of the program

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Weight Loss at the end of the weight loss program (at Week 13)
Time Frame: At week 13 of the RCT.
Weight measured at the Week 13 weigh-in session. Weight measurements are taken by trained research assistants using digital scales.
At week 13 of the RCT.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Weight Loss at the end of the post-intervention period (Week 25)
Time Frame: At week 25 of the RCT.
Weight measured at the Week 25 weigh-in session. Weight measurements are taken by trained research assistants using digital scales.
At week 25 of the RCT.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

October 12, 2015

Primary Completion (ACTUAL)

June 22, 2016

Study Completion (ACTUAL)

June 22, 2016

Study Registration Dates

First Submitted

May 11, 2018

First Submitted That Met QC Criteria

May 11, 2018

First Posted (ACTUAL)

May 23, 2018

Study Record Updates

Last Update Posted (ACTUAL)

August 22, 2018

Last Update Submitted That Met QC Criteria

August 20, 2018

Last Verified

August 1, 2018

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • A-14-071

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Individual participant data that underlie the results reported in the research, after de-identification (text, tables, figures, and appendices).

IPD Sharing Time Frame

Beginning 3 months and ending 5 years following article publication.

IPD Sharing Access Criteria

Investigators whose proposed use of the data has been approved by an independent review committee identified for this purpose.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Health Knowledge, Attitudes, Practice

Clinical Trials on Incentive for Education

3
Subscribe